Overall market sentiment has been high on Zomedica Corp (ZOM) stock lately. ZOM receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.
Zomedica Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ZOM!
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With ZOM Stock Today?
Zomedica Corp (ZOM) stock is higher by 23.44% while the S&P 500 is lower by -0.75% as of 9:44 AM on Thursday, Feb 17. ZOM is higher by $0.09 from the previous closing price of $0.38 on volume of 659,356 shares. Over the past year the S&P 500 has risen 12.93% while ZOM is lower by -80.17%. ZOM lost -$0.02 per share in the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Zomedica Corp click here.
More About Zomedica Corp
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs.
Click Here to get the full Stock Report for Zomedica Corp stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
